Navigation Links
Protein found that may provide relief from neuropathic pain
Date:12/5/2007

Neuropathic pain is caused by injury to the peripheral nerves in diseases such as HIV/AIDS, shingles, and cancer or in repetitive motion disorders and trauma, and does not respond well to conventional pain-relieving drugs.

Research in rodents by scientists from the University of California, San Diego (UCSD) School of Medicine has provided evidence that a protein called LRP1 may help to ease neuropathic pain by blocking the response of glial cells that support and protect sensory neurons in the peripheral nervous system. Their findings, which could represent a novel target for neuropathic pain therapy, are published in the December 3 issue of the Journal of Clinical Investigation.

Neuropathic pain differs from ordinary pain in that it is usually perceived as ongoing burning or as pins and needles electric-shock type of sensation, said Wendy Campana, Ph.D., associate professor in UCSDs Department of Anesthesiology, who led the study. It is caused by nerve damage that can be associated with chronic inflammation or direct nerve injury.

The UCSD studies show that a form of LRP1 that is present in body fluids such as blood counteracts the activity of inflammatory cytokines, proteins which are involved in developing and sustaining chronic pain states. Cytokines act as messengers to either stimulate or inhibit the immune response, are produced by many cell types including white blood cells present during infection and inflammation

We think that the anti-inflammatory activity of LRP1 can be harnessed to decrease chronic pain, said Campana. By decreasing the presence of cytokines in the area of nerve damage, LRP1 calms the pain signals that are sent to the spinal cord.

In-vitro analysis confirmed that LRP1 works to modify the response of glial cells that results in neuropathic pain, according to Campana, who added that interactions of neurons and glial cells are very important in determining pain.

Campana worked with post-doctoral scholar Alban Gaultier, Ph.D., and Steven L. Gonias, M.D., chair of UCSDs Department of Pathology, who are exploring other aspects of LRP1 function. The UCSD scientists observed that injured peripheral nerves in both mice and rats release LRP1 into the surrounding tissue. Administration of LRP1 into the rodents sciatic nerves prior to injury provided a protective effect, decreasing the level and activity of injury-induced proinflammatory cytokines, such as TNF-alpha, in the local environment and inhibiting spontaneous pain.

In addition to decreasing inflammatory cytokines locally, treatment with LRP1 also decreased inflammatory cytokines in a region called the spinal dorsal horn, where central pain processing occurs.

TNF-alpha has some positive properties in infection, so you may not want to block its activity entirely, said Campana. It appears that LRP1 limits, but doesnt completely block, the increase in proinflammatory cytokines produced by glial cells after nerve injury. We think this research opens up a number of new research directions for understanding and treating chronic neuropathic pain.


'/>"/>

Contact: Debra Kain
ddkain@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert

Related medicine news :

1. Draining away brains toxic protein to stop Alzheimers
2. Penn study finds pro-death proteins required to regulate healthy immune function
3. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
4. Emory researchers identify signaling protein for multiple myeloma
5. Human C-reactive protein regulates myeloma tumor cell growth and survival
6. Lowering Blood Protein Wont Help Kidney Patients
7. Blood protein detects lung cancer, even at earliest stage
8. Natural Protein Could Help Spot, Treat Liver Cancer
9. Heat shock proteins are co-opted for cancer
10. How adhesive protein causes malaria
11. Loss of gene leads to protein splicing and buildup of toxic proteins in neurons
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... ... Dr. Travis Schwarz is an experienced dentist who leads Riverheart Family Dentistry ... patients of all ages with a full menu of dental services, including preventative, ... superior patient reviews that he has consistently earned during his practice experience. It was ...
(Date:5/25/2016)... Livonia, MI (PRWEB) , ... May 25, 2016 , ... ... honors Allstate has to bestow: the Dick McKenna Good Hands Legacy Award. McKenna ran ... commitment to others which continues to inspire all those who knew him. The award ...
(Date:5/25/2016)... ... May 25, 2016 , ... TransactRx announces the release of ... medical service claims by Pharmacy Benefit Managers that were submitted by Retail Clinics ... TransactRx Cross Benefit Clearinghouse receives standard professional medical claims submitted from the retail ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... America ... that Carol Reichbaum, M.S.L., M.S.P.A., of the University of Pittsburgh Graduate School of ... Fellowship will enable Ms. Reichbaum and 24 other advocates from around the country to ...
(Date:5/25/2016)... Fort Wayne, IN (PRWEB) , ... May 25, ... ... of supplemental group health insurance, has seen a significant spike in their clients' ... in their annual biometric health screening by implementing a high-deductible health plan ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... According to market research ... and Demand Forecast to 2022 - Industry Insights ... (Drug Discovery and Development, Proteomics, Clinical Testing, Environment ... and Biotechnology, Academic and Research Institute, Hospitals and ... mass spectrometry market was valued at ...
(Date:5/23/2016)... , UAE, May 23, 2016 ... importance of Precision Medicine and the role of ...   The First International Conference of VPS-Penn ... the distinguished patronage and presence of Sheikh Nahyan bin Mubarak ... focused in Precision Medicine, which helps provide personalized medicine and ...
(Date:5/22/2016)... , May 23, 2016 ... develop its anti-fibrotic and anti-inflammatory compound DS102 in ... as in non-alcoholic steatohepatitis (NASH) patients. ... significantly sequestered in lung tissue and has bronchodilatory, ... after oral administration. The Company will publish further ...
Breaking Medicine Technology: